Jubilant Pharmova Q2 Results: Net profit jumps 64% YoY to Rs 103 crore; stock falls marginally

Jubilant Pharmova reported a 64.5% increase in second-quarter profit, reaching Rs 103 crore for the quarter ending September 30, up from Rs 62.5 crore a year earlier, driven by strong demand for radiopharma drugs. Revenue grew 4.5% to Rs 1,742 crore, with the radiopharma segment seeing nearly 11% growth.